Causaly alternatives and competitors
The closest alternatives to Causaly are BenchSci, Edison Scientific, Owkin and Medvolt.
Causaly supplies scientific AI software for pharmaceutical, biotechnology and academic research. Its agents combine biomedical literature, knowledge graphs and an organization's internal evidence to investigate questions, compare findings and produce assessments.
6 alternatives to Causaly
What each product does, with its price as the vendor publishes it.
-
B
BenchSci develops EMET, an AI research environment for scientists in biopharma and academia. The platform combines scientific literature, experimental databases and internal research with a biomedical knowledge graph.
Price: Free limited academic access; custom enterprise pricing
-
E
Edison Scientific is the commercial spinout of the nonprofit research lab FutureHouse, formed in November 2025 to run its AI scientist platform.
Price: Free academic usage, $200 per Kosmos run at launch, enterprise quoted separately
-
O
Tech bio company building what it calls an AI scientist for biopharma research and development, combining biological reasoning models, a multimodal patient data network and agentic software.
Price: Free for academic researchers (K Navigator), not published for K Pro
-
M
Medvolt, based in Pune, India, sells MedGraph, an AI and physics based in silico platform for early drug discovery, to pharmaceutical and biotechnology companies as software modules and as delivered projects.
Price: No published price
-
S
Computational chemistry software company (Nasdaq: SDGR) whose physics based molecular simulation platform is licensed to pharmaceutical, biotechnology, industrial and academic organizations, alongside a proprietary therapeutics pipeline built on the same platform.
Price: No published price
-
I
Iktos is a Paris generative AI and robotics company for small molecule drug discovery, founded in 2016.
Price: No published price
Causaly alternatives, answered
What are the best alternatives to Causaly?
The closest alternatives to Causaly are BenchSci, Edison Scientific, Owkin, Medvolt and Schrödinger. BenchSci develops EMET, an AI research environment for scientists in biopharma and academia. Edison Scientific is the commercial spinout of the nonprofit research lab FutureHouse, formed in November 2025 to run its AI scientist platform. Medvolt, based in Pune, India, sells MedGraph, an AI and physics based in silico platform for early drug discovery, to pharmaceutical and biotechnology companies as software modules and as delivered projects.
Who are Causaly's competitors?
Causaly's competitors in the Drug Discovery AI category include BenchSci, Edison Scientific, Owkin, Medvolt, Schrödinger and Iktos.